#1 Clinical Trials Search in Europe

Theophylline

Theophylline, a medication traditionally used to treat respiratory conditions, is being investigated for its potential benefits in various medical conditions. Clinical trials are exploring its effects on bronchiectasis, syncope, diaphragmatic dysfunction, chronic obstructive pulmonary disease (COPD), and pseudohypoparathyroidism. These studies aim to evaluate theophylline’s efficacy, safety, and potential new applications in different patient populations.

Table of Contents

What is Theophylline?

Theophylline is a medication that has been used for decades to treat various respiratory conditions. It belongs to a class of drugs called methylxanthines and is known by several brand names, including Theo-24 and Elixophyllin[7]. Theophylline works by relaxing the muscles in the airways and reducing inflammation, making it easier for patients to breathe.

Conditions Treated with Theophylline

Theophylline is primarily used to treat respiratory conditions, but research is ongoing to explore its potential in other areas. Some of the conditions it is used to treat or being studied for include:

  • Chronic Obstructive Pulmonary Disease (COPD): Theophylline can help improve breathing in patients with COPD, a group of lung diseases that cause airflow blockage and breathing-related problems[1][10].
  • Bronchiectasis: This is a condition where the airways of the lungs become abnormally widened, leading to a build-up of excess mucus. Theophylline may help improve symptoms in patients with non-cystic fibrosis bronchiectasis[1].
  • Syncope: Also known as fainting, syncope is being studied to see if theophylline can help prevent recurrent episodes in certain patients[2].
  • Pseudohypoparathyroidism: This rare genetic disorder affects how the body responds to certain hormones. Researchers are investigating whether theophylline can help with symptoms like obesity and short stature in children with this condition[6][7].

How Theophylline Works

Theophylline works in several ways to help patients with respiratory and other conditions:

  • Bronchodilation: It relaxes the smooth muscles in the airways, making them wider and easier to breathe through[1].
  • Anti-inflammatory effects: Theophylline can reduce inflammation in the airways, which is particularly helpful in conditions like COPD and bronchiectasis[1].
  • Improved mucociliary clearance: This means it helps the body clear mucus from the airways more effectively[1].
  • Phosphodiesterase inhibition: Theophylline inhibits an enzyme called phosphodiesterase, which can lead to various effects in the body, including improved function of certain hormones[6].

How Theophylline is Administered

Theophylline can be given in several forms, depending on the condition being treated and the patient’s needs:

  • Oral tablets or capsules: These are often sustained-release formulations, taken once or twice daily[1].
  • Oral liquid (elixir): This form may be used for patients who have difficulty swallowing pills or for more frequent dosing[7].
  • Intravenous (IV) infusion: In some cases, theophylline may be given through an IV, especially in hospital settings[5].

The dosage of theophylline is carefully determined based on the patient’s condition, age, weight, and other factors. Regular blood tests may be needed to monitor the level of theophylline in the body and adjust the dose as necessary.

Ongoing Research and Potential New Uses

Researchers are exploring new potential uses for theophylline beyond its traditional role in respiratory conditions. Some areas of ongoing research include:

  • Diaphragm function in critically ill patients: Studies are looking at whether theophylline can improve the function of the diaphragm, the main muscle used for breathing, in patients in intensive care units[3].
  • Genetic variations in drug metabolism: Researchers are studying how genetic differences might affect how people process theophylline, which could help in personalizing treatment[4][8].
  • Hormone-related disorders: Theophylline is being studied for its potential to help with conditions like pseudohypoparathyroidism, where the body doesn’t respond properly to certain hormones[9].

Potential Side Effects and Monitoring

While theophylline can be an effective medication for many patients, it can also cause side effects, especially if blood levels become too high. Some potential side effects include:

  • Nausea or vomiting
  • Headache
  • Insomnia
  • Rapid heartbeat (palpitations)
  • Irregular heart rhythms (arrhythmias)[1]

Because of these potential side effects, doctors often monitor theophylline levels in the blood to ensure the dose is in the right range. This is especially important because the way theophylline is processed in the body can vary between individuals and can be affected by factors like other medications, diet, and smoking[4][8].

Condition Study Focus Key Outcomes Measured
Bronchiectasis Efficacy and safety of 24-week theophylline treatment Quality of life, exacerbation frequency, cough, sputum volume, lung function
Syncope Effect on asystolic events in patients with low adenosine Number of asystolic syncope events, time to first syncope recurrence
Diaphragmatic Dysfunction Improvement in diaphragm function in critically ill patients Diaphragm thickness and excursion, weaning from mechanical ventilation
COPD Genetic factors affecting theophylline metabolism Plasma concentrations of theophylline and its metabolites
Pseudohypoparathyroidism Effects on various aspects of the condition in children and young adults Body mass index, bone age, glucose tolerance, hormone resistance

FAQ

  • What conditions are being studied with theophylline in clinical trials? Clinical trials are investigating theophylline's potential benefits in bronchiectasis, syncope, diaphragmatic dysfunction in critically ill patients, chronic obstructive pulmonary disease (COPD), and pseudohypoparathyroidism.
  • How is theophylline being studied in bronchiectasis patients? In a clinical trial for bronchiectasis, researchers are examining the efficacy and safety of 24 weeks of theophylline treatment. They are measuring outcomes such as quality of life, exacerbation frequency, cough, sputum volume, and lung function.
  • What is the potential use of theophylline in syncope patients? Theophylline is being studied in patients with unexplained syncope (fainting) and low adenosine levels. The trial aims to assess if theophylline can reduce asystolic events (periods when the heart stops beating) in these patients.
  • How is theophylline being used in critically ill patients? A study is investigating the use of theophylline to improve diaphragmatic function in critically ill patients. Researchers are using ultrasound to measure changes in diaphragm thickness and movement after theophylline treatment.
  • What is being studied about theophylline in pseudohypoparathyroidism patients? Several trials are exploring theophylline's potential to address various aspects of pseudohypoparathyroidism, including its effects on body mass index, bone age, glucose tolerance, and hormone resistance in children and young adults with this condition.

Ongoing Clinical Trials on Theophylline

  • Study on Theophylline for Improving Exercise Capacity in Adolescents with Univentricular Heart Disease and Fontan Circulation

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway

Glossary

  • Theophylline: A medication traditionally used to treat respiratory conditions like asthma and COPD. It works by relaxing airway muscles and reducing inflammation.
  • Bronchiectasis: A chronic lung condition where the airways become abnormally widened, leading to a build-up of excess mucus that can make the lungs more vulnerable to infection.
  • Syncope: A temporary loss of consciousness, often referred to as fainting, usually related to insufficient blood flow to the brain.
  • Diaphragmatic dysfunction: A condition where the diaphragm, the main muscle used for breathing, doesn't work properly, which can lead to breathing difficulties.
  • Chronic Obstructive Pulmonary Disease (COPD): A group of lung diseases, including chronic bronchitis and emphysema, that cause airflow blockage and breathing-related problems.
  • Pseudohypoparathyroidism: A rare genetic disorder characterized by the body's inability to respond properly to parathyroid hormone, leading to various health issues including low blood calcium levels.
  • Asystole: A state of no cardiac electrical activity, also known as flatline, which is the most serious form of cardiac arrest.
  • Cyclic adenosine monophosphate (cAMP): A molecule that acts as a second messenger in many biological processes, playing a crucial role in how cells respond to hormones.
  • Phosphodiesterase (PDE) inhibitor: A type of drug that blocks the action of phosphodiesterase enzymes, which break down cAMP. By inhibiting these enzymes, PDE inhibitors can prolong and enhance the effects of cAMP in the body.

References

  1. https://clinicaltrials.gov/study/NCT01684683
  2. https://clinicaltrials.gov/study/NCT03803215
  3. https://clinicaltrials.gov/study/NCT04269187
  4. https://clinicaltrials.gov/study/NCT03015090
  5. https://clinicaltrials.gov/study/NCT02463409
  6. https://clinicaltrials.gov/study/NCT04551170
  7. https://clinicaltrials.gov/study/NCT03029429
  8. https://clinicaltrials.gov/study/NCT02001935
  9. https://clinicaltrials.gov/study/NCT03718403
  10. https://clinicaltrials.gov/study/NCT00671151